You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 30 No. 1, January 1974 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Depression Subtypes and Response to Phenelzine, Diazepam, and a Placebo

Results of a Nine Hospital Collaborative Study

Allen Raskin, PhD; Joy G. Schulterbrandt, MS; Natalie Reatig; Thomas H. Crook, MA; David Odle

Arch Gen Psychiatry. 1974;30(1):66-75.


Abstract

A total of 325, newly admitted, depressed patients from nine hospitals were randomly assigned to treatment with either diazepam, phenelzine, or a placebo. The study was conducted double-blind and ran for seven weeks. Median daily dosages were 30 mg of diazepam and 45 mg of phenelzine.

The major study finding was the differential effects of diazepam for patients categorized as anxious and hostile depressions. There was a significant number of anxious-depressive patients who were diazepam responders, ie, their symptoms subsided on this treatment and became worse when this drug was discontinued.

In contrast, diazepam was a poor treatment for the hostile depressions. These patients were restless, anxious, negativistic, suspicious, and irritable when they entered the study. These symptoms persisted on diazepam and improved on either phenelzine or a placebo.



Author Affiliations

Rockville, Md

From the National Institute of Mental Health, Psychopharmacology Research Branch, Rockville, Md (Drs. Raskin and Schulterbrandt and N. Reatig and T. Crook), and George Washington University, Biometrics Laboratory, Kensington, Md (D. Odle).


Footnotes

Accepted for publication Sept 12, 1973.

Reprint requests to Rm 9-101 NIMH, 5600 Fishers Lane, Rockville, Md 20852 (Dr. Raskin).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Depressive Symptoms and Depressive Diagnoses in a Community Population: Use of a New Procedure for Analysis of Psychiatric Classification
Blazer et al.
Arch Gen Psychiatry 1988;45:1078-1084.
ABSTRACT  

An Efficacy Study of Isocarboxazid and Placebo in Depression, and Its Relationship to Depressive Nosology
Davidson et al.
Arch Gen Psychiatry 1988;45:120-127.
ABSTRACT  

Antidepressants: Their efficacy and place in therapy
Paykel
J Psychopharmacol 1988;2:105-118.
ABSTRACT  

Panic Disorder and Major Depression: Increased Risk of Depression, Alcoholism, Panic, and Phobic Disorders in Families of Depressed Probands With Panic Disorder
Leckman et al.
Arch Gen Psychiatry 1983;40:1055-1060.
ABSTRACT  

Response to Phenelzine and Amitriptyline in Subtypes of Outpatient Depression
Paykel et al.
Arch Gen Psychiatry 1982;39:1041-1049.
ABSTRACT  

Monoamine Oxidase Inhibitors: A Review of Antidepressant Effectiveness
Quitkin et al.
Arch Gen Psychiatry 1979;36:749-760.
ABSTRACT  

Benzodiazepines in Depressive Disorders
Schatzberg and Cole
Arch Gen Psychiatry 1978;35:1359-1365.
ABSTRACT  

Clinical Pharmacology of Phenelzine
Robinson et al.
Arch Gen Psychiatry 1978;35:629-635.
ABSTRACT  

Clinical Implications of Imipramine Plasma Levels for Depressive Illness
Glassman et al.
Arch Gen Psychiatry 1977;34:197-204.
ABSTRACT  

A Multiple-Dose, Controlled Study of Phenelzine in Depression-Anxiety States
Ravaris et al.
Arch Gen Psychiatry 1976;33:347-350.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1974 American Medical Association. All Rights Reserved.